Plante Moran Financial Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $85.5K | Buy |
677
+308
| +83% | +$40.6K | ﹤0.01% | 268 |
|
|
2026
Q1 | $51.4K | Sell |
369
-158
| -30% | -$22.1K | ﹤0.01% | 308 |
|
|
2025
Q4 | $64.7K | Buy |
527
+103
| +24% | +$12.5K | ﹤0.01% | 290 |
|
|
2025
Q3 | $47.1K | Hold |
424
| – | – | ﹤0.01% | 348 |
|
|
2025
Q2 | $47K | Hold |
424
| – | – | ﹤0.01% | 342 |
|
|
2025
Q1 | $47.5K | Sell |
424
-2,800
| -87% | -$289K | ﹤0.01% | 351 |
|
|
2024
Q4 | $298K | Hold |
3,224
| – | – | 0.02% | 130 |
|
|
2024
Q3 | $270K | Sell |
3,224
-400
| -11% | -$30.5K | 0.02% | 142 |
|
|
2024
Q2 | $249K | Hold |
3,624
| – | – | 0.02% | 153 |
|
|
2024
Q1 | $265K | Hold |
3,624
| – | – | 0.03% | 143 |
|
|
2023
Q4 | $294K | Buy |
3,624
+2,800
| +340% | +$218K | 0.03% | 128 |
|
|
2023
Q3 | $61.8K | Hold |
824
| – | – | 0.01% | 271 |
|
|
2023
Q2 | $63.5K | Hold |
824
| – | – | 0.01% | 269 |
|
|
2023
Q1 | $68.4K | Sell |
824
-100
| -11% | -$8.28K | 0.01% | 258 |
|
|
2022
Q4 | $79.3K | Buy |
924
+32
| +4% | +$2.53K | 0.01% | 254 |
|
|
2022
Q3 | $55K | Sell |
892
-501
| -36% | -$31.6K | 0.01% | 289 |
|
|
2022
Q2 | $86K | Buy |
1,393
+501
| +56% | +$31K | 0.01% | 234 |
|
|
2022
Q1 | $53K | Sell |
892
-597
| -40% | -$38.2K | 0.01% | 323 |
|
|
2021
Q4 | $108K | Buy |
1,489
+108
| +8% | +$7.44K | 0.02% | 238 |
|
|
2021
Q3 | $96K | Sell |
1,381
-330
| -19% | -$23.2K | 0.02% | 280 |
|
|
2021
Q2 | $118K | Buy |
1,711
+400
| +31% | +$26.7K | 0.03% | 231 |
|
|
2021
Q1 | $85K | Sell |
1,311
-676
| -34% | -$43.6K | 0.02% | 271 |
|
|
2020
Q4 | $116K | Sell |
1,987
-1,400
| -41% | -$84.5K | 0.04% | 233 |
|
|
2020
Q3 | $214K | Buy |
3,387
+2,400
| +243% | +$166K | 0.08% | 137 |
|
|
2020
Q2 | $76K | Buy |
987
+68
| +7% | +$5.21K | 0.03% | 247 |
|
|
2020
Q1 | $69K | Buy |
919
+86
| +10% | +$5.94K | 0.03% | 222 |
|
|
2019
Q4 | $54K | Sell |
833
-475
| -36% | -$30.9K | 0.02% | 312 |
|
|
2019
Q3 | $83K | Buy |
1,308
+54
| +4% | +$3.53K | 0.02% | 265 |
|
|
2019
Q2 | $85K | Sell |
1,254
-2,800
| -69% | -$184K | 0.03% | 245 |
|
|
2019
Q1 | $264K | Hold |
4,054
| – | – | 0.08% | 124 |
|
|
2018
Q4 | $254K | Buy |
4,054
+26
| +0.6% | +$1.82K | 0.09% | 118 |
|
|
2018
Q3 | $311K | Buy |
4,028
+2,874
| +249% | +$217K | 0.1% | 111 |
|
|
2018
Q2 | $82K | Sell |
1,154
-1,123
| -49% | -$79.3K | 0.04% | 250 |
|
|
2018
Q1 | $172K | Sell |
2,277
-566
| -20% | -$45K | 0.09% | 167 |
|
|
2017
Q4 | $204K | Buy |
2,843
+1,350
| +90% | +$103K | 0.11% | 135 |
|
|
2017
Q3 | $121K | Sell |
1,493
-112
| -7% | -$8.56K | 0.07% | 177 |
|
|
2017
Q2 | $114K | Sell |
1,605
-558
| -26% | -$37.1K | 0.07% | 183 |
|
|
2017
Q1 | $147K | Sell |
2,163
-613
| -22% | -$43.1K | 0.09% | 160 |
|
|
2016
Q4 | $199K | Buy |
2,776
+537
| +24% | +$39.9K | 0.12% | 122 |
|
|
2016
Q3 | $177K | Buy |
2,239
+764
| +52% | +$62.1K | 0.12% | 129 |
|
|
2016
Q2 | $123K | Buy |
1,475
+235
| +19% | +$20.9K | 0.09% | 159 |
|
|
2016
Q1 | $114K | Buy |
1,240
+101
| +9% | +$9.11K | 0.09% | 160 |
|
|
2015
Q4 | $115K | Sell |
1,139
-393
| -26% | -$40.9K | 0.09% | 167 |
|
|
2015
Q3 | $150K | Buy |
1,532
+67
| +5% | +$7.44K | 0.12% | 137 |
|
|
2015
Q2 | $172K | Hold |
1,465
| – | – | 0.12% | 127 |
|
|
2015
Q1 | $144K | Hold |
1,465
| – | – | 0.1% | 148 |
|
|
2014
Q4 | $138K | Sell |
1,465
-128
| -8% | -$13.2K | 0.1% | 145 |
|
|
2014
Q3 | $170K | Buy |
1,593
+348
| +28% | +$34.1K | 0.15% | 108 |
|
|
2014
Q2 | $103K | Buy |
1,245
+945
| +315% | +$73.6K | 0.09% | 148 |
|
|
2014
Q1 | $21K | Sell |
300
-1,063
| -78% | -$83.4K | 0.02% | 243 |
|
|
2013
Q4 | $102K | Buy |
1,363
+830
| +156% | +$57.8K | 0.06% | 153 |
|
|
2013
Q3 | $34K | Buy |
533
+363
| +214% | +$21.7K | 0.02% | 229 |
|
|
2013
Q2 | $9K | Buy |
+170
| New | +$8.86K | 0.01% | 364 |
|
Other funds holding GILD
Plante Moran Financial Advisors's GILD Position: Q2 2026 in Review
Plante Moran Financial Advisors increased its Gilead Sciences (GILD) stake by 83% in Q2 2026, buying an estimated $40.6K and bringing the position to 677 shares worth $85.5K. The position accounts for ﹤0.01% of the portfolio, ranked #268.
Plante Moran Financial Advisors first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $311K in Q3 2018. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Plante Moran Financial Advisors held 677 shares of Gilead Sciences worth $85.5K as of Q2 2026.
- Plante Moran Financial Advisors bought 308 Gilead Sciences shares in Q2 2026, an estimated $40.6K.
- Gilead Sciences made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #268 holding.
- Plante Moran Financial Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Plante Moran Financial Advisors's Gilead Sciences position peaked at $311K in Q3 2018.
- 1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.